6533b833fe1ef96bd129c362

RESEARCH PRODUCT

Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings

Velthorst E.Mollon J.Murray R. M.De Haan L.Germeys I. M.Glahn D. C.Arango C.Van Der Ven E.Di Forti M.Bernardo M.Guloksuz S.Delespaul P.Mezquida G.Amoretti S.Bobes J.Saiz P. A.Garcia-portilla M. P.Santos J. L.Jimenez-lopez E.Sanjuan J.Aguilar E. J.Arrojo M.Carracedo A.Lopez G.Gonzalez-penas J.Parellada M.Atbasoglu C.Saka M. C.Ucok A.Alptekin K.Akdede B.Binbay T.Altinyazar V.Ulas H.Yalincetin B.Gumus-akay G.Beyaz B. C.Soygur H.Cankurtaran E. S.Kaymak S. U.Maric N. P.Mihaljevic M. M.Petrovic S. A.Mirjanic T.Del-ben C. M.Ferraro L.Gayer-anderson C.Jones P. B.Jongsma H. E.Kirkbride J. B.La Cascia C.Lasalvia A.Tosato S.Llorca P. -M.Menezes P. R.Morgan C.Quattrone D.Menchetti M.Selten J. -P.Szoke A.Tarricone I.Tortelli A.Mcguire P.Valmaggia L.Kempton M. J.Van Der Gaag M.Riecher-rossler A.Bressan R. A.Barrantes-vidal N.Nelson B.Mcgorry P.Pantelis C.Krebs M. -O.Ruhrmann S.Sachs G.Rutten B. P. F.Van Os J.Alizadeh B. Z.Van Amelsvoort T.Bartels-velthuis A. A.Bruggeman R.Van Beveren N. J.Luykx J. J.Cahn W.Simons C. J. P.Kahn R. S.Schirmbeck F.Van Winkel R.Calem M.Tognin S.Modinos G.Pisani S.Kraan T. C.Van Dam D. S.Burger N.Amminger G. P.Politis A.Goodall J.Borgwardt S.Studerus E.Gadelha A.Brietzke E.Asevedo G.Asevedo E.Zugman A.Dominguez-martinez T.Monsonet M.Cristobal-narvaez P.Racioppi A.Kwapil T. R.Kazes M.Daban C.Bourgin J.Gay O.Mam-lam-fook C.Nordholm D.Rander L.Krakauer K.Glenthoj L. B.Glenthoj B.Gebhard D.Arnhold J.Klosterkotter J.Lasser I.Winklbaur B.Reichenberg A.

subject

0301 basic medicinevaliditymedicine.medical_treatmentCHILDHOODNeuropsychological TestsFAMÍLIAepisodeCognition0302 clinical medicineDEFICITSSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.MedicineCognitive impairmentPsychiatrySymptom severityCannabis useIMPAIRMENTABILITYPsychiatry and Mental healthSchizophreniaRELIABILITYNeuropsychological TestLife Sciences & BiomedicineHumanClinical psychologyAdultBiochemistry & Molecular Biologyimpairmentschizophrenia-patientsabilityGENETIC RISKPsychotic DisorderSCHIZOPHRENIA-PATIENTS03 medical and health sciencesCellular and Molecular NeuroscienceSDG 3 - Good Health and Well-beingSettore M-PSI/08 - Psicologia ClinicaHumansIn patientCognitive skillVALIDITYAntipsychoticMolecular BiologySettore MED/25 - PsichiatriaAgedCross-Sectional StudieDECLINEScience & Technologyreliabilitybusiness.industryWorking memorySiblingsNeurosciencesDiagnostic markersmedicine.diseaseCross-Sectional Studies030104 developmental biologydeficitsPsychotic DisordersSchizophreniaPSYCHOSIS COGNITION MULTICENTRIC STUDYNeurosciences & NeurologybusinessEPISODE030217 neurology & neurosurgery

description

The European Community’s Seventh Framework Programme under grant agreement No. HEALTH-F2-2010-241909 (EUGEI); The Spanish sample was supported by the Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III (SAM16PE07CP1, PI16/02012, PI19/024) (...)

yearjournalcountryeditionlanguage
2021-08-01Molecular Psychiatry
10.1038/s41380-020-00969-zhttps://doi.org/10.1038/s41380-020-00969-z